|
| 38058200 | CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia. | Haematologica | 2024 |
| 38001171 | Prognostic implications of CD9 in childhood acute lymphoblastic leukemia: insights from a nationwide multicenter study in China. | Leukemia | 2024 |
| 36346962 | Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial. | J Clin Oncol | 2023 |
| 37487146 | Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials. | J Clin Oncol | 2023 |
| 37790080 | Effect of the tyrosine kinase inhibitors on the growth in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case-control study. | Lancet Reg Health West Pac | 2023 |
| 37579533 | Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel. | Cancer Treat Rev | 2023 |
| 37543655 | Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia. | Leukemia | 2023 |
| 37986997 | Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very young. | medRxiv | 2023 |
| 38047975 | The association of environmental factors with neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia (ALL). | Support Care Cancer | 2023 |
| 35837830 | Vaccines against SARS-CoV-2 are safe to administer in patients with antibodies to pegaspargase. | Cancer Med | 2023 |
| 37058475 | Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia. | Blood Adv | 2023 |
| 37289547 | Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia. | Blood Adv | 2023 |
| 37285328 | Genetic variants, neurocognitive outcomes, and functional neuroimaging in survivors of childhood acute lymphoblastic leukemia. | JNCI Cancer Spectr | 2023 |
| 36943896 | Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods. | Cancer | 2023 |
| 36943767 | Prognostic factors of childhood acute lymphoblastic leukemia with TCF3::PBX1 in CCCG-ALL-2015: A multicenter study. | Cancer | 2023 |
| 37076694 | Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia. | Leukemia | 2023 |
| 37301632 | Olverembatinib Treatment in Pediatric Patients With Relapsed Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia. | Clin Lymphoma Myeloma Leuk | 2023 |
| 36576946 | Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia. | Blood Adv | 2023 |
| 36711662 | Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia. | bioRxiv | 2023 |
| 36537587 | Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia. | Cancer | 2023 |
| 36604538 | Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response. | Nat Med | 2023 |
| 36798219 | Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment. | medRxiv | 2023 |
| 36798219 | Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment. | medRxiv | 2023 |
| 36824825 | Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures. | bioRxiv | 2023 |
| 36824825 | Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures. | bioRxiv | 2023 |
| 36309560 | Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group. | Leukemia | 2023 |
| 36352514 | Characterisation of children and adolescents with acute lymphoblastic leukaemia who presented without peripheral blood blasts at diagnosis. | Br J Haematol | 2023 |
| 36256911 | Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study. | J Clin Oncol | 2023 |
| 34192312 | Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium. | Blood | 2022 |
| 35442732 | Simultaneous monitoring of disease and microbe dynamics through plasma DNA sequencing in pediatric patients with acute lymphoblastic leukemia. | Sci Adv | 2022 |
| 35441457 | Dasatinib-therapy induced sustained remission in a child with refractory TCF7-SPI1 T-cell acute lymphoblastic leukemia. | Pediatr Blood Cancer | 2022 |
| 35675514 | Impact of T-cell immunity on chemotherapy response in childhood acute lymphoblastic leukemia. | Blood | 2022 |
| 35767897 | International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. | Blood | 2022 |
| 35344039 | Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication. | Clin Cancer Res | 2022 |
| 35671062 | Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia. | Blood Adv | 2022 |
| 35603857 | Sex-Based Differences in Functional Brain Activity During Working Memory in Survivors of Pediatric Acute Lymphoblastic Leukemia. | JNCI Cancer Spectr | 2022 |
| 35446934 | Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL. | Blood Adv | 2022 |
| 35849135 | Human Astrovirus VA1 Encephalitis in Pediatric Patients With Cancer: Report of 2 Cases and Review of the Literature. | J Pediatric Infect Dis Soc | 2022 |
| 36516256 | PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia. | Sci Adv | 2022 |
| 36876164 | Functional Outcomes for Children, Adolescents, and Young Adults with Osteonecrosis following Hip Core Decompression. | Rehabil Oncol | 2022 |
| 36001679 | Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia. | Sci Transl Med | 2022 |
| 36104354 | Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia. | Nat Commun | 2022 |
| 35963521 | Sequential Approach to Improve the Molecular Classification of Childhood Acute Lymphoblastic Leukemia. | J Mol Diagn | 2022 |
| 36389386 | Energy cost of walking in obese survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort. | Front Pediatr | 2022 |
| 36322880 | The Impact of Intensified CNS-Directed Therapy on Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated Without Cranial Irradiation. | J Clin Oncol | 2022 |
| 36114009 | Extended vincristine and dexamethasone pulse therapy may not be necessary for children with TCF3-PBX1 positive acute lymphoblastic leukaemia. | Br J Haematol | 2022 |
| 34980876 | Association between CEP72 genotype and persistent neuropathy in survivors of childhood acute lymphoblastic leukemia. | Leukemia | 2022 |
| 34875402 | Impact of High Disease Burden on Survival in Pediatric Patients with B-ALL Treated with Tisagenlecleucel. | Transplant Cell Ther | 2022 |
| 35115686 | Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation. | Nat Genet | 2022 |
| 35115686 | Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation. | Nat Genet | 2022 |